Literature DB >> 15085135

Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis.

Takako Koga1, Masanori Inui, Kazuya Inoue, Sunhwa Kim, Ayako Suematsu, Eiji Kobayashi, Toshio Iwata, Hiroshi Ohnishi, Takashi Matozaki, Tatsuhiko Kodama, Tadatsugu Taniguchi, Hiroshi Takayanagi, Toshiyuki Takai.   

Abstract

Costimulatory signals are required for activation of immune cells, but it is not known whether they contribute to other biological systems. The development and homeostasis of the skeletal system depend on the balance between bone formation and resorption. Receptor activator of NF-kappaB ligand (RANKL) regulates the differentiation of bone-resorbing cells, osteoclasts, in the presence of macrophage-colony stimulating factor (M-CSF). But it remains unclear how RANKL activates the calcium signals that lead to induction of nuclear factor of activated T cells c1, a key transcription factor for osteoclastogenesis. Here we show that mice lacking immunoreceptor tyrosine-based activation motif (ITAM)-harbouring adaptors, Fc receptor common gamma subunit (FcRgamma) and DNAX-activating protein (DAP)12, exhibit severe osteopetrosis owing to impaired osteoclast differentiation. In osteoclast precursor cells, FcRgamma and DAP12 associate with multiple immunoreceptors and activate calcium signalling through phospholipase Cgamma. Thus, ITAM-dependent costimulatory signals activated by multiple immunoreceptors are essential for the maintenance of bone homeostasis. These results reveal that RANKL and M-CSF are not sufficient to activate the signals required for osteoclastogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15085135     DOI: 10.1038/nature02444

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  299 in total

1.  Interleukin-33 stimulates formation of functional osteoclasts from human CD14(+) monocytes.

Authors:  Se Hwan Mun; Na Young Ko; Hyuk Soon Kim; Jie Wan Kim; Do Kyun Kim; A-Ram Kim; Seung Hyun Lee; Yong-Gil Kim; Chang Keun Lee; Seoung Hoon Lee; Bo Kyung Kim; Michael A Beaven; Young Mi Kim; Wahn Soo Choi
Journal:  Cell Mol Life Sci       Date:  2010-06-08       Impact factor: 9.261

2.  The transmembrane adaptor protein, linker for activation of T cells (LAT), regulates RANKL-induced osteoclast differentiation.

Authors:  Kabsun Kim; Jung Ha Kim; Jang Bae Moon; Jongwon Lee; Han Bok Kwak; Yong-Wook Park; Nacksung Kim
Journal:  Mol Cells       Date:  2012-02-28       Impact factor: 5.034

Review 3.  Inflammatory bone loss: pathogenesis and therapeutic intervention.

Authors:  Kurt Redlich; Josef S Smolen
Journal:  Nat Rev Drug Discov       Date:  2012-03-01       Impact factor: 84.694

Review 4.  The skeletal subsystem as an integrative physiology paradigm.

Authors:  Aaron J Weiss; Jameel Iqbal; Neeha Zaidi; Jeffrey I Mechanick
Journal:  Curr Osteoporos Rep       Date:  2010-12       Impact factor: 5.096

Review 5.  Cellular communications in bone homeostasis and repair.

Authors:  Ken-Ichi Nakahama
Journal:  Cell Mol Life Sci       Date:  2010-08-08       Impact factor: 9.261

Review 6.  Osteoclastogenesis and arthritis.

Authors:  Nicola Maruotti; Maria Grano; Silvia Colucci; Francesca d'Onofrio; Francesco Paolo Cantatore
Journal:  Clin Exp Med       Date:  2010-11-11       Impact factor: 3.984

Review 7.  Calcium signaling in osteoclasts.

Authors:  Sung-Yong Hwang; James W Putney
Journal:  Biochim Biophys Acta       Date:  2010-11-11

8.  The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.

Authors:  Hyun-Ju Kim; Kaihua Zhang; Lihong Zhang; F Patrick Ross; Steven L Teitelbaum; Roberta Faccio
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-26       Impact factor: 11.205

Review 9.  TREM and TREM-like receptors in inflammation and disease.

Authors:  Jill W Ford; Daniel W McVicar
Journal:  Curr Opin Immunol       Date:  2009-02-21       Impact factor: 7.486

Review 10.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.